Robert J Mentz1, Melissa A Greiner2, Adam D DeVore2, Shannon M Dunlay2, Gaurav Choudhary2, Tariq Ahmad2, Prateeti Khazanie2, Tiffany C Randolph2, Michael E Griswold2, Zubin J Eapen2, Emily C O'Brien2, Kevin L Thomas2, Lesley H Curtis2, Adrian F Hernandez2. 1. From the Department of Medicine, Division of Cardiology, Duke University School of Medicine (R.J.M., A.D.D., T.A., P.K., T.C.R., Z.J.E., E.C.O'B., K.L.T., A.F.H.), and Duke Clinical Research Institute (R.J.M., M.A.G., A.D.D., T.C.R., Z.J.E., E.C.O'B., K.L.T., L.H.C., A.F.H.), Durham, NC; Department of Medicine, Mayo Clinic, Rochester, MN (S.M.D.); Vascular Research Laboratory, Providence VA Medical Center and Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI (G.C.); and Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS (M.E.G.). robert.mentz@duke.edu. 2. From the Department of Medicine, Division of Cardiology, Duke University School of Medicine (R.J.M., A.D.D., T.A., P.K., T.C.R., Z.J.E., E.C.O'B., K.L.T., A.F.H.), and Duke Clinical Research Institute (R.J.M., M.A.G., A.D.D., T.C.R., Z.J.E., E.C.O'B., K.L.T., L.H.C., A.F.H.), Durham, NC; Department of Medicine, Mayo Clinic, Rochester, MN (S.M.D.); Vascular Research Laboratory, Providence VA Medical Center and Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI (G.C.); and Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS (M.E.G.).
Abstract
BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and mortality in African Americans. METHODS AND RESULTS: We analyzed data from 5146 African Americans in the Jackson Heart Study stratified by QRS duration on baseline 12-lead ECG. We defined QRS prolongation as QRS≥100 ms. We assessed the association between QRS duration and all-cause mortality using Cox proportional hazards models and reported the cumulative incidence of heart failure hospitalization. We identified factors associated with the development of QRS prolongation in patients with normal baseline QRS. At baseline, 30% (n=1528) of participants had QRS prolongation. The cumulative incidences of mortality and heart failure hospitalization were greater with versus without baseline QRS prolongation: 12.6% (95% confidence interval [CI], 11.0-14.4) versus 7.1% (95% CI, 6.3-8.0) and 8.2% (95% CI, 6.9-9.7) versus 4.4% (95% CI, 3.7-5.1), respectively. After risk adjustment, QRS prolongation was associated with increased mortality (hazard ratio, 1.27; 95% CI, 1.03-1.56; P=0.02). There was a linear relationship between QRS duration and mortality (hazard ratio per 10 ms increase, 1.06; 95% CI, 1.01-1.12). Older age, male sex, prior myocardial infarction, lower ejection fraction, left ventricular hypertrophy, and left ventricular dilatation were associated with the development of QRS prolongation. CONCLUSIONS: QRS prolongation in African Americans was associated with increased mortality and heart failure hospitalization. Factors associated with developing QRS prolongation included age, male sex, prior myocardial infarction, and left ventricular structural abnormalities.
BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and mortality in African Americans. METHODS AND RESULTS: We analyzed data from 5146 African Americans in the Jackson Heart Study stratified by QRS duration on baseline 12-lead ECG. We defined QRS prolongation as QRS≥100 ms. We assessed the association between QRS duration and all-cause mortality using Cox proportional hazards models and reported the cumulative incidence of heart failure hospitalization. We identified factors associated with the development of QRS prolongation in patients with normal baseline QRS. At baseline, 30% (n=1528) of participants had QRS prolongation. The cumulative incidences of mortality and heart failure hospitalization were greater with versus without baseline QRS prolongation: 12.6% (95% confidence interval [CI], 11.0-14.4) versus 7.1% (95% CI, 6.3-8.0) and 8.2% (95% CI, 6.9-9.7) versus 4.4% (95% CI, 3.7-5.1), respectively. After risk adjustment, QRS prolongation was associated with increased mortality (hazard ratio, 1.27; 95% CI, 1.03-1.56; P=0.02). There was a linear relationship between QRS duration and mortality (hazard ratio per 10 ms increase, 1.06; 95% CI, 1.01-1.12). Older age, male sex, prior myocardial infarction, lower ejection fraction, left ventricular hypertrophy, and left ventricular dilatation were associated with the development of QRS prolongation. CONCLUSIONS: QRS prolongation in African Americans was associated with increased mortality and heart failure hospitalization. Factors associated with developing QRS prolongation included age, male sex, prior myocardial infarction, and left ventricular structural abnormalities.
Authors: Kathy Hebert; Henry C Quevedo; Leonardo Tamariz; Andre Dias; Dylan L Steen; Rosario A Colombo; Emiliana Franco; Sholom Neistein; Lee M Arcement Journal: Ann Noninvasive Electrocardiol Date: 2012-04 Impact factor: 1.468
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: J Am Coll Cardiol Date: 2013-06-05 Impact factor: 24.094
Authors: Robert J Mentz; Vera Bittner; Phillip J Schulte; Jerome L Fleg; Ileana L Piña; Steven J Keteyian; Gordon Moe; Anil Nigam; Ann M Swank; Anekwe E Onwuanyi; Meredith Fitz-Gerald; Andrew Kao; Stephen J Ellis; William E Kraus; David J Whellan; Christopher M O'Connor Journal: Am Heart J Date: 2013-07-12 Impact factor: 4.749
Authors: Aapo L Aro; Olli Anttonen; Jani T Tikkanen; M Juhani Junttila; Tuomas Kerola; Harri A Rissanen; Antti Reunanen; Heikki V Huikuri Journal: Circ Arrhythm Electrophysiol Date: 2011-08-13
Authors: Janina M Jeff; Kristin Brown-Gentry; Sarah G Buxbaum; Daniel F Sarpong; Herman A Taylor; Alfred L George; Dan M Roden; Dana C Crawford Journal: Circ Cardiovasc Genet Date: 2011-02-15
Authors: Barbara E Bussink; Anders G Holst; Lasse Jespersen; Jaap W Deckers; Gorm B Jensen; Eva Prescott Journal: Eur Heart J Date: 2012-09-04 Impact factor: 29.983
Authors: Daniel S Evans; Christy L Avery; Mike A Nalls; Guo Li; John Barnard; Erin N Smith; Toshiko Tanaka; Anne M Butler; Sarah G Buxbaum; Alvaro Alonso; Dan E Arking; Gerald S Berenson; Joshua C Bis; Steven Buyske; Cara L Carty; Wei Chen; Mina K Chung; Steven R Cummings; Rajat Deo; Charles B Eaton; Ervin R Fox; Susan R Heckbert; Gerardo Heiss; Lucia A Hindorff; Wen-Chi Hsueh; Aaron Isaacs; Yalda Jamshidi; Kathleen F Kerr; Felix Liu; Yongmei Liu; Kurt K Lohman; Jared W Magnani; Joseph F Maher; Reena Mehra; Yan A Meng; Solomon K Musani; Christopher Newton-Cheh; Kari E North; Bruce M Psaty; Susan Redline; Jerome I Rotter; Renate B Schnabel; Nicholas J Schork; Ralph V Shohet; Andrew B Singleton; Jonathan D Smith; Elsayed Z Soliman; Sathanur R Srinivasan; Herman A Taylor; David R Van Wagoner; James G Wilson; Taylor Young; Zhu-Ming Zhang; Alan B Zonderman; Michele K Evans; Luigi Ferrucci; Sarah S Murray; Gregory J Tranah; Eric A Whitsel; Alex P Reiner; Nona Sotoodehnia Journal: Hum Mol Genet Date: 2016-08-29 Impact factor: 6.150
Authors: Daisuke Kamimura; Loretta R Cain; Robert J Mentz; Wendy B White; Michael J Blaha; Andrew P DeFilippis; Ervin R Fox; Carlos J Rodriguez; Rachel J Keith; Emelia J Benjamin; Javed Butler; Aruni Bhatnagar; Rose M Robertson; Michael D Winniford; Adolfo Correa; Michael E Hall Journal: Circulation Date: 2018-04-16 Impact factor: 29.690
Authors: Christopher A Pumill; Christopher G Bush; Melissa A Greiner; Michael E Hall; Shannon M Dunlay; Adolfo Correa; Lesley H Curtis; Takeki Suzuki; Chantelle Hardy; Chad T Blackshear; Emily C O'Brien; Robert J Mentz Journal: Am Heart J Date: 2019-03-08 Impact factor: 4.749
Authors: Arun Krishnamoorthy; Melissa A Greiner; Alain G Bertoni; Zubin J Eapen; Emily C O'Brien; Lesley H Curtis; Adrian F Hernandez; Robert J Mentz Journal: J Card Fail Date: 2016-03-11 Impact factor: 5.712
Authors: Kishan S Parikh; Melissa A Greiner; Wei Wang; Yuan-I Min; Adolfo Correa; Benjamin F Banahan; Lesley H Curtis; Adrian F Hernandez; Emily C O'Brien; Robert J Mentz Journal: Epidemiology Date: 2017-09 Impact factor: 4.822
Authors: Tiffany C Randolph; Melissa A Greiner; Chidiebube Egwim; Adrian F Hernandez; Kevin L Thomas; Lesley H Curtis; Paul Muntner; Wei Wang; Robert J Mentz; Emily C O'Brien Journal: J Am Heart Assoc Date: 2016-12-07 Impact factor: 5.501
Authors: Daisuke Kamimura; Takeki Suzuki; Solomon K Musani; Michael E Hall; Tandaw E Samdarshi; Adolfo Correa; Ervin R Fox Journal: J Am Heart Assoc Date: 2017-06-21 Impact factor: 5.501
Authors: Tiffany C Randolph; Samuel Broderick; Linda K Shaw; Karen Chiswell; Robert J Mentz; Valentina Kutyifa; Eric J Velazquez; Francis R Gilliam; Kevin L Thomas Journal: J Am Heart Assoc Date: 2017-03-20 Impact factor: 5.501
Authors: Patrick Koo; Annie Gjelsvik; Gaurav Choudhary; Wen-Chih Wu; Wei Wang; F Dennis McCool; Charles B Eaton Journal: J Am Heart Assoc Date: 2017-09-07 Impact factor: 5.501
Authors: Bram P Prins; Timothy J Mead; Jennifer A Brody; Gardar Sveinbjornsson; Ioanna Ntalla; Nathan A Bihlmeyer; Marten van den Berg; Jette Bork-Jensen; Stefania Cappellani; Stefan Van Duijvenboden; Nikolai T Klena; George C Gabriel; Xiaoqin Liu; Cagri Gulec; Niels Grarup; Jeffrey Haessler; Leanne M Hall; Annamaria Iorio; Aaron Isaacs; Ruifang Li-Gao; Honghuang Lin; Ching-Ti Liu; Leo-Pekka Lyytikäinen; Jonathan Marten; Hao Mei; Martina Müller-Nurasyid; Michele Orini; Sandosh Padmanabhan; Farid Radmanesh; Julia Ramirez; Antonietta Robino; Molly Schwartz; Jessica van Setten; Albert V Smith; Niek Verweij; Helen R Warren; Stefan Weiss; Alvaro Alonso; David O Arnar; Michiel L Bots; Rudolf A de Boer; Anna F Dominiczak; Mark Eijgelsheim; Patrick T Ellinor; Xiuqing Guo; Stephan B Felix; Tamara B Harris; Caroline Hayward; Susan R Heckbert; Paul L Huang; J W Jukema; Mika Kähönen; Jan A Kors; Pier D Lambiase; Lenore J Launer; Man Li; Allan Linneberg; Christopher P Nelson; Oluf Pedersen; Marco Perez; Annette Peters; Ozren Polasek; Bruce M Psaty; Olli T Raitakari; Kenneth M Rice; Jerome I Rotter; Moritz F Sinner; Elsayed Z Soliman; Tim D Spector; Konstantin Strauch; Unnur Thorsteinsdottir; Andrew Tinker; Stella Trompet; André Uitterlinden; Ilonca Vaartjes; Peter van der Meer; Uwe Völker; Henry Völzke; Melanie Waldenberger; James G Wilson; Zhijun Xie; Folkert W Asselbergs; Marcus Dörr; Cornelia M van Duijn; Paolo Gasparini; Daniel F Gudbjartsson; Vilmundur Gudnason; Torben Hansen; Stefan Kääb; Jørgen K Kanters; Charles Kooperberg; Terho Lehtimäki; Henry J Lin; Steven A Lubitz; Dennis O Mook-Kanamori; Francesco J Conti; Christopher H Newton-Cheh; Jonathan Rosand; Igor Rudan; Nilesh J Samani; Gianfranco Sinagra; Blair H Smith; Hilma Holm; Bruno H Stricker; Sheila Ulivi; Nona Sotoodehnia; Suneel S Apte; Pim van der Harst; Kari Stefansson; Patricia B Munroe; Dan E Arking; Cecilia W Lo; Yalda Jamshidi Journal: Genome Biol Date: 2018-07-17 Impact factor: 13.583